Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study
By
Caroline J. Bull,
Joshua A Bell,
Neil Murphy,
Eleanor N Sanderson,
George Davey Smith,
NJ Timpson,
Barbara L. Banbury,
Demetrius Albanes,
Sonja I. Berndt,
Stéphane Bézieau,
D Timothy T. Bishop,
Hermann Brenner,
Daniel D Buchanan,
Andrea Burnett-Hartman,
Graham Casey,
Sergi Castellví-Bel,
Andrew T Chan,
Jenny Chang-Claude,
Amanda J. Cross,
Albert de la Chapelle,
Jane C. Figueiredo,
Steven J. Gallinger,
Sue M. Gapstur,
Graham G Giles,
Stephen B. Gruber,
Andrea Gsur,
Jochen Hampe,
Heather Hampel,
Tabitha A Harrison,
Michael Hoffmeister,
Li Hsu,
Wen-Yi Huang,
Jeroen R. Huyghe,
Mark A. Jenkins,
Corinne E Joshu,
Temitope O Keku,
Tilman Kühn,
Sun-Seog Kweon,
Loic Le Marchand,
Christopher I. Li,
Li Li,
Annika Lindblom,
Vicente Martín,
Anne M May,
Roger L. Milne,
Victor Moreno,
Polly A. Newcomb,
Kenneth Offit,
Shuji Ogino,
Amanda I. Phipps,
Elizabeth A. Platz,
John D. Potter,
Conghui Qu,
J. Ramón Quirós,
Gad Rennert,
Elio Riboli,
Lori C. Sakoda,
Clemens Schafmayer,
Robert E. Schoen,
Martha L. Slattery,
Catherine M. Tangen,
Kostas K. Tsilidis,
Cornelia M. Ulrich,
Franzel JB van Duijnhoven,
Bethany Van Guelpen,
Kala Visvanathan,
Pavel Vodicka,
Ludmila Vodickova,
Hansong Wang,
Emily White,
Alicja Wolk,
Michael O Woods,
Anna H. Wu,
Peter T. Campbell,
Wei Zheng,
Ulrike Peters,
Emma E Vincent,
Marc J Gunter
Posted 20 Mar 2020
medRxiv DOI: 10.1101/2020.03.19.20031138
ImportanceEvidence on adiposity altering colorectal cancer (CRC) risk differently among men and women, and on metabolic alterations mediating effects of adiposity on CRC, is unclear. ObjectiveTo examine sex- and site-specific associations of adiposity with CRC risk, and whether adiposity-associated metabolites explain associations of adiposity with CRC. DesignTwo-sample Mendelian randomization (MR) study. SettingGenetic variants from expanded genome-wide association studies of body mass index (BMI) and waist-to-hip ratio (WHR, unadjusted for BMI; N=806,810), and 123 metabolites (mostly lipoprotein subclass-specific lipids) from targeted nuclear magnetic resonance metabolomics (N=24,925), were used as instruments. Sex-combined and sex-specific MR was conducted for BMI and WHR with CRC risk; sex-combined MR was conducted for BMI and WHR with metabolites, for metabolites with CRC, and for BMI and WHR with CRC adjusted for metabolite classes. Participants58,221 cases and 67,694 controls (Genetics and Epidemiology of Colorectal Cancer Consortium; Colorectal Cancer Transdisciplinary Study; Colon Cancer Family Registry). Main outcome measuresIncident CRC (overall and site-specific). ResultsAmong men, higher BMI (per 4.2 kg/m2) was associated with 1.23 (95%-confidence interval (CI)=1.08, 1.38) times higher CRC odds (inverse-variance-weighted (IVW) model); among women, higher BMI (per 5.2 kg/m2) was associated with 1.09 (95%-CI=0.97, 1.22) times higher CRC odds. Higher WHR was more strongly associated with CRC risk among women (IVW-OR=1.25, 95%-CI=1.08, 1.43 per 0.07-ratio) than men (IVW-OR=1.05, 95%-CI=0.81, 1.36 per 0.07-ratio). BMI or WHR was associated with 104 metabolites (false-discovery-rate-corrected P[≤]0.05) including low-density lipoprotein (LDL) cholesterol, but these metabolites were generally unassociated with CRC in directions consistent with mediation of adiposity-CRC relations. In multivariable MR, associations of BMI and WHR with CRC were not attenuated following adjustment for representative metabolite classes - e.g. the univariable IVW-OR of BMI for CRC was 1.12 (95%-CI=1.00, 1.26), and 1.11 (95%-CI=0.99, 1.26) adjusting for LDL lipids. Conclusions and relevanceOur results suggest that higher BMI more greatly raises CRC risk among men, whereas higher WHR more greatly raises CRC risk among women. Adiposity was associated with numerous metabolic alterations, but none of these alterations explained associations between adiposity and CRC. More detailed metabolomic measures are likely needed to clarify mechanistic pathways.
Download data
- Downloaded 337 times
- Download rankings, all-time:
- Site-wide: 73,657
- In epidemiology: 3,049
- Year to date:
- Site-wide: 68,605
- Since beginning of last month:
- Site-wide: 54,569
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!